Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Optimi Health Corp C.OPTI

Alternate Symbol(s):  OPTHF

Optimi Health Corp. is an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances, such as 3,4-Methylenedioxymethamphetamine (MDMA), natural Manufacturing Practices (GMP)-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets. The Company produces scalable... see more

CSE:OPTI - Post Discussion

Optimi Health Corp > Opti Made It's Run -- NEXT Silo Wellness 📈🤝🏾
View:
Post by GajjarDr on Oct 10, 2022 2:44pm

Opti Made It's Run -- NEXT Silo Wellness 📈🤝🏾

Was lucky to have got word of gem early June before stock picked up. Next in line; SILO WELLNESS add them to your Psychedelic watch list. greenmarketreport.com/oregons-silo-wellness-buys-dyscovry-science-to-aid-psychedelic-retreats/
Comment by StockhouseUser on Oct 10, 2022 3:23pm
GREAT 12 MINUTE LISTEN \ /
Comment by CyberSecurity on Oct 11, 2022 8:32pm
What makes you so sure Gajjar?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities